Compare IRON & BAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRON | BAND |
|---|---|---|
| Founded | 2017 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.3B |
| IPO Year | 2020 | 2017 |
| Metric | IRON | BAND |
|---|---|---|
| Price | $76.82 | $46.86 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 7 |
| Target Price | ★ $103.17 | $66.50 |
| AVG Volume (30 Days) | ★ 939.1K | 799.9K |
| Earning Date | 11-05-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $204,113,000.00 |
| Revenue This Year | N/A | $20.15 |
| Revenue Next Year | N/A | $4.32 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 25.26 |
| 52 Week Low | $40.00 | $12.50 |
| 52 Week High | $99.50 | $79.08 |
| Indicator | IRON | BAND |
|---|---|---|
| Relative Strength Index (RSI) | 64.49 | 41.06 |
| Support Level | $73.04 | $43.18 |
| Resistance Level | $83.09 | $56.74 |
| Average True Range (ATR) | 3.70 | 3.69 |
| MACD | 2.43 | -1.55 |
| Stochastic Oscillator | 81.23 | 21.70 |
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of its revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.